The aquaculture bacterial disease treatment market is projected to grow from USD 2.1 billion in 2026 to USD 4.6 billion by 2036, at a CAGR of 8.1%. Antibiotics will dominate with a 46.0% market share, while aeromonas infections will lead the applications segment with a 34.0% share.